Screenshot 2018-11-26 17.46.28.png
TMS Associates of Pennsylvania First Facility in the State to Treat Obsessive-Compulsive Disorder (OCD) with Deep Transcranial Magnetic Stimulation (Deep TMS)
November 27, 2018 08:00 ET | TMS Associates of Pennsylvania LLC
HAVERFORD, Pa., Nov. 27, 2018 (GLOBE NEWSWIRE) -- TMS Associates of Pennsylvania LLC, Haverford’s leading mental health provider specializing in mood disorders, announced today that it is now...
BransWay logo.jpg
Sandhya Prashad, M.D., Now Offering BrainsWay Deep TMS to Patients With Depression in Houston Area
July 10, 2018 09:00 ET | Brainsway Ltd.
BELLAIRE, Texas, July 10, 2018 (GLOBE NEWSWIRE) -- Houston psychiatrist Sandhya Prashad, M.D., today announced that her practice is now offering BrainsWay Deep Transcranial Magnetic Stimulation...
BransWay logo.jpg
Achieve TMS Announces Grand Opening of New Location in Newton, Massachusetts
May 23, 2018 09:54 ET | Brainsway Ltd.
NEWTON, Mass., May 23, 2018 (GLOBE NEWSWIRE) -- Achieve TMS, the largest U.S. provider of BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS), announced the opening of a new facility in...
BrainsWay 2021 logo.jpg
Trinitas-St. Joseph’s Behavioral Health Network Offers Innovative Alternative Treatment for Depression
April 04, 2018 08:00 ET | Brainsway Ltd.
PATERSON, N.J., April 04, 2018 (GLOBE NEWSWIRE) -- The Trinitas-St. Joseph’s Behavioral Health Network is now offering Transcranial Magnetic Stimulation (TMS) as a treatment option for individuals...
BrainsWay 2021 logo.jpg
Walter Reed National Military Medical Center Acquires a Brainsway Deep TMS System to Enhance its Treatment of Depression
June 22, 2017 17:12 ET | Brainsway Ltd.
HACKENSACK, N.J., June 22, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, today...
BrainsWay 2021 logo.jpg
Brainsway® Announces Positive Final Results of its Deep TMS Multicenter Study in Obsessive Compulsive Disorder (OCD) Patients
June 12, 2017 12:35 ET | Brainsway Ltd.
Brainsway will prepare a submission to the FDA to market the device for OCD Deep TMS treatment led to statistically significant and meaningful improvements in patients suffering from OCD Patients...